CATABASIS PHARMACEUTICALS INC Underwriting Agreements
9 Contracts & Agreements
- Underwriting Agreement, dated January 30, 2024, by and among Astria Therapeutics, Inc., Jefferies LLC and Evercore Group L.L.C (Filed With SEC on January 31, 2024)
- Underwriting Agreement, dated October 11, 2023, by and among Astria Therapeutics, Inc., Jefferies LLC and Evercore Group L.L.C (Filed With SEC on October 12, 2023)
- Underwriting Agreement, dated December 15, 2022, by and among Astria Therapeutics, Inc., Jefferies LLC and Evercore Group L.L.C (Filed With SEC on December 15, 2022)
- Underwriting Agreement, dated January 30, 2020, by and between the Company and Oppenheimer & Co. Inc (Filed With SEC on January 30, 2020)
- Underwriting Agreement, dated February 6, 2019, by and between the Company and Oppenheimer & Co. Inc (Filed With SEC on February 6, 2019)
- Underwriting Agreement, dated June 19, 2018, by and between the Company and the Underwriter (Filed With SEC on June 20, 2018)
- Form of Underwriting Agreement (Filed With SEC on June 12, 2018)
- Catabasis Pharmaceuticals, Inc. 2,500,000 Shares Common Stock ($0.001 par value per share) Underwriting Agreement (Filed With SEC on September 23, 2016)
- Catabasis Pharmaceuticals, Inc. Shares Common Stock ($0.001 par value per share) Underwriting Agreement (Filed With SEC on June 11, 2015)
